Home THIS WEBSITE IS INTENDED FOR HEALTHCARE PROFESSIONALS (HCPs) ONLY

Sylvant logo Menu

Welcome to the SYLVANT®
Healthcare Professional site

Latest Resources

Prescribing Information

View All Resources

Idiopathic Multicentric Castleman Disease (iMCD)
prevalence and patient outlook

iMCD is a very heterogenous disease and there is no typical patient. Uncontrolled iMCD can lead to severe organ damage, increased risk of developing cancers and death1

iMCD prevalence and patient outlook

References
1. Liu AY et al. The Lancet Haematology 2016
2. Fajgenbaum DC et al. Blood 2017; 129(12): 1646-1657